Community Health Systems INC

Market Movers (8-K)

NYSE
Community Health Systems reported a 9.8% decrease in net operating revenues for Q2 2026, alongside a significant drop in net income, though same-store revenues saw a modest increase.
Worse than expected
NYSE
Community Health Systems has finalized the sale of four Arkansas hospitals and associated facilities to Freeman Health System for $110 million.
NYSE
Community Health Systems reported a net loss of $58 million for the first quarter of 2026, citing divestitures and lower patient volumes.
Worse than expected
NYSE
Community Health Systems, Inc. completed the sale of Crestwood Medical Center and its associated facilities for $459 million in cash, impacting pro forma financials.
Worse than expected
NYSE
Community Health Systems announced a definitive agreement to divest four Arkansas hospitals and related outpatient facilities to Freeman Health System for $112 million.
NYSE
Community Health Systems' Board approved 2026 compensation packages for its key executive officers, including base salaries, cash incentives, and long-term equity awards.

Quarterly Earnings (10-Q)

NYSE
Community Health Systems reports a significant decrease in net income for Q2 2026 compared to the prior year, driven by lower revenues and increased operating expenses, despite positive same-store revenue growth.
Worse than expected
NYSE
Community Health Systems reports a net loss of $58 million for Q1 2026 amid divestiture activity and regulatory headwinds.
Worse than expected
NYSE
Community Health Systems reported a significant turnaround in Q3 2025, moving from a net loss to a net income, driven by divestiture gains and tax benefits, despite regulatory headwinds.
Delay expected
Better than expected
Capital raise
NYSE
Community Health Systems, Inc. reported a significant turnaround to net income in the second quarter of 2025, largely due to gains from hospital divestitures and early extinguishment of debt, despite facing ongoing regulatory challenges and declining consolidated admissions.
Capital raise
Better than expected
NYSE
Community Health Systems reports a net income of $25 million for Q1 2025, a significant improvement from the net loss in Q1 2024, while navigating hospital divestitures and strategic financial maneuvers.
Better than expected
Capital raise
NYSE
Community Health Systems reported a net loss of $391 million for the third quarter of 2024, impacted by impairment charges, a change in professional liability claims estimates, and hurricane-related expenses.
Worse than expected

Annual Reports (10-K)

NYSE
Community Health Systems, Inc. reported a significant turnaround in 2025 with $509 million in net income, driven by strategic divestitures and an income tax benefit, despite a slight decrease in consolidated net operating revenues.
Delay expected
Better than expected
NYSE
Community Health Systems releases its 10-K filing, detailing financial results for the fiscal year ended December 31, 2024, including revenue, expenses, and strategic initiatives.
Worse than expected
NYSE
CHS/Community Health Systems, Inc. executes supplemental indentures to guarantee obligations for various series of senior secured notes.

Insider Trading (Form 4)

NYSE
Director Krishnan K Ranga reported a transaction involving Community Health Systems Inc. (CYH) common stock and restricted stock units.
NYSE
EVP-Clinical Operations & CMO David V. Rice was granted 30,000 shares of restricted stock and 30,000 stock options as part of a compensation package.
NYSE
Director K. Ranga Krishnan acquired 46,950 shares of Community Health Systems common stock through the settlement of restricted stock units.
NYSE
Community Health Systems EVP Kevin Stockton reported significant stock option exercises, restricted stock vesting, and new equity grants.
NYSE
Community Health Systems' SVP & CAO, Phillip A. Posey, received grants of restricted stock and stock options totaling 75,000 equity awards.
NYSE
Justin D. Pitt, President, Chief Legal & Admin Officer of Community Health Systems, reported significant equity transactions, including vesting of performance shares and new awards.

Proxy Statements (Def-14A)

NYSE
Community Health Systems has filed a definitive proxy statement with the SEC regarding its upcoming shareholder meeting.
NYSE
Community Health Systems announces its 2025 Annual Meeting of Stockholders to be held on May 13, 2025, featuring proposals on director elections, executive compensation, and corporate governance amendments.
Worse than expected
NYSE
Community Health Systems, Inc. announces its 2024 Annual Meeting of Shareholders to be held on May 7, 2024, outlining key proposals for voting.
NYSE
Community Health Systems will hold its 2024 Annual Meeting of Stockholders on May 7, 2024, to vote on director elections, executive compensation, and the ratification of the independent accounting firm.
Worse than expected

Schedule 13G - Passive Investments

NYSE
Apollo Management Holdings and affiliated entities have filed a Schedule 13G reporting an 8.2% beneficial ownership stake in Community Health Systems, Inc.
NYSE
CastleKnight Master Fund LP and affiliated entities have reported a 9% beneficial ownership stake in Community Health Systems Inc.
NYSE
He Zhengxu has reported beneficial ownership of 7,410,784 shares, representing 5.3% of the outstanding Common Stock of Community Health Systems Inc., as of May 14, 2026.
NYSE
The Vanguard Group has reported a 0% beneficial ownership in Community Health Systems Inc. following an internal realignment.
NYSE
Eversept Partners, L.P. and its affiliates have reported a beneficial ownership of 5.73% in Community Health Systems, Inc., holding 7,943,802 shares.
NYSE
Apollo Management Holdings GP, LLC and its affiliates report an 8.5% beneficial ownership stake in Community Health Systems, Inc.